BROADCASTS.com

b"Every week, The American Journal of Managed Care recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\\n\\nThis week, the top managed care news included the bipartisan deal to stabilize the Affordable Care Act's insurance markets; coverage from the Academy of Managed Care Pharmacy 2017 Nexus; a plan to reduce clinician burnout at the computer; and an FDA advisory panel has recommended approval for semaglutide, a once-weekly GLP-1 receptor agonist.\\n\\nRead more about the stories in this episode:\\nDeal Reached to Keep Health Insurance Subsidies: www.ajmc.com/focus-of-the-week/1017/Deal-Reached-to-Keep-Health-Insurance-Subsidies\\n\\nThe Academy of Managed Care Pharmacy Nexus 2017: www.ajmc.com/conferences/amcp-nexus-2017\\n\\nKite Pharma's CAR T-Cell Treatment Approved, Cheaper Than Tisagenlecleucel: www.ajmc.com/newsroom/kite-pharmas-car-t-cell-treatment-approved-cheaper-than-tisagenlecleucel\\n\\nAMA Seeks to Make Health Data Work Better for Doctors, Patients: www.ajmc.com/focus-of-the-week/1017/AMA-Seeks-to-Make-Health-Data-Work-Better-for-Doctors-Patients\\n\\nACO & Emerging Healthcare Delivery Coalition Fall 2017: www.ajmc.com/acocoalition/fall17\\n\\nFDA Panel Gives Nod to Once-Weekly Semaglutide for Type 2 Diabetes: www.ajmc.com/newsroom/fda-panel-gives-nod-to-once-weekly-semaglutide-for-type-2-diabetes\\n\\nEvidence-Based Oncology, October 2017: www.ajmc.com/journals/evidence-based-oncology/2017/October-2017"